AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2010
Mar 30, 2010
33651_dirs_2010-03-30_8fe3c516-481f-463d-b639-380de4ac89ef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RXI PHARMACEUTICALS CORP (RXII)
CIK: 0001390478
Period of Report: 2010-03-26
Reporting Person: Hillsberg Sanford (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-26 | Common Stock | S | 25000 | $5.66 | Disposed | 6000 | Direct |
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9